GlaxoSmithKline PLC ADR (GSK) — Capital Reinvestment Ratio
GlaxoSmithKline PLC ADR (GSK) has a Capital Reinvestment Ratio of 0.13x as of June 2026, meaning it reinvests 0% of its operating cash flow ($2.54 Billion) in capital expenditures ($328.95 Million). Check GSK tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
GlaxoSmithKline PLC ADR Capital Reinvestment Ratio (1990–2025)
This chart tracks GlaxoSmithKline PLC ADR's Capital Reinvestment Ratio across 36 annual periods. For the full cash flow conversion analysis, see GlaxoSmithKline PLC ADR (GSK) cash conversion ratio.
Annual Capital Reinvestment Ratio for GlaxoSmithKline PLC ADR (1990–2025)
Year-by-year Capital Reinvestment Ratio for GlaxoSmithKline PLC ADR from 1990 to 2025. See cash generation quality of GlaxoSmithKline PLC ADR to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.18x | $7.14 Billion | $1.32 Billion | ▼ -59.4% |
| 2024 | 0.45x | $6.55 Billion | $2.98 Billion | ▲ +119.8% |
| 2023 | 0.21x | $7.89 Billion | $1.63 Billion | ▼ -32.1% |
| 2022 | 0.31x | $7.40 Billion | $2.26 Billion | ▼ -17.2% |
| 2021 | 0.37x | $7.95 Billion | $2.93 Billion | ▲ +39.0% |
| 2020 | 0.27x | $8.44 Billion | $2.24 Billion | ▼ -1.6% |
| 2019 | 0.27x | $8.02 Billion | $2.16 Billion | ▲ +26.5% |
| 2018 | 0.21x | $8.42 Billion | $1.80 Billion | ▼ -33.0% |
| 2017 | 0.32x | $6.92 Billion | $2.20 Billion | ▼ -12.1% |
| 2016 | 0.36x | $6.50 Billion | $2.35 Billion | ▼ -51.1% |
| 2015 | 0.74x | $2.57 Billion | $1.90 Billion | ▲ +118.7% |
| 2014 | 0.34x | $5.18 Billion | $1.75 Billion | ▲ +43.6% |
| 2013 | 0.24x | $7.22 Billion | $1.70 Billion | ▼ -32.2% |
| 2012 | 0.35x | $4.38 Billion | $1.52 Billion | ▲ +63.5% |
| 2011 | 0.21x | $6.25 Billion | $1.33 Billion | ▼ -11.7% |
| 2010 | 0.24x | $6.80 Billion | $1.64 Billion | ▲ +0.7% |
| 2009 | 0.24x | $7.84 Billion | $1.87 Billion | ▼ -15.6% |
| 2008 | 0.28x | $7.31 Billion | $2.07 Billion | ▼ -18.6% |
| 2007 | 0.35x | $6.17 Billion | $2.14 Billion | ▼ -10.9% |
| 2006 | 0.39x | $4.08 Billion | $1.59 Billion | ▲ +104.6% |
| 2005 | 0.19x | $6.20 Billion | $1.18 Billion | ▲ +269.3% |
| 2004 | 0.05x | $4.94 Billion | $255.00 Million | ▼ -76.4% |
| 2003 | 0.22x | $4.85 Billion | $1.06 Billion | ▼ -45.4% |
| 2002 | 0.40x | $3.06 Billion | $1.23 Billion | ▲ +65.4% |
| 2001 | 0.24x | $4.61 Billion | $1.12 Billion | ▼ -59.3% |
| 2000 | 0.60x | $1.85 Billion | $1.10 Billion | ▼ -49.1% |
| 1999 | 1.17x | $510.00 Million | $597.00 Million | ▲ +1.0% |
| 1998 | 1.16x | $410.00 Million | $475.00 Million | ▲ +71.7% |
| 1997 | 0.67x | $615.00 Million | $415.00 Million | ▲ +42.9% |
| 1996 | 0.47x | $849.00 Million | $401.00 Million | ▼ -13.5% |
| 1995 | 0.55x | $1.25 Billion | $684.00 Million | ▲ +175.5% |
| 1994 | 0.20x | $2.45 Billion | $485.59 Million | ▼ -63.7% |
| 1993 | 0.55x | $1.05 Billion | $575.00 Million | ▼ -16.7% |
| 1992 | 0.66x | $927.00 Million | $608.00 Million | ▼ -27.5% |
| 1991 | 0.90x | $657.00 Million | $594.00 Million | ▼ -8.2% |
| 1990 | 0.99x | $615.00 Million | $606.00 Million | — |